ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
20.107,56
1,00%
S&P 500
6.012,35
1,18%
Dow Jones
42.996,97
0,62%
Euro vs US Dollar
1,03865
0,79%
Bitcoin
101.658,32
3,38%
Pepperstone
Advertisement
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Xenetic Biosciences Inc (XBIO)

  7. Xenetic Biosciences Inc (XBIO) News

XBIO

Xenetic Biosciences (XBIO)

Xenetic Biosciences Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:XBIO
DatumZeitQuelleÜberschriftSymbolFirma
13/12/202423h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XBIOXenetic Biosciences Inc
13/12/202423h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XBIOXenetic Biosciences Inc
13/12/202423h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XBIOXenetic Biosciences Inc
13/12/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XBIOXenetic Biosciences Inc
13/11/202414h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XBIOXenetic Biosciences Inc
07/11/202415h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XBIOXenetic Biosciences Inc
04/11/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:XBIOXenetic Biosciences Inc
31/10/202422h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XBIOXenetic Biosciences Inc
31/10/202421h50Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:XBIOXenetic Biosciences Inc
31/10/202421h40Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:XBIOXenetic Biosciences Inc
31/10/202421h30Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:XBIOXenetic Biosciences Inc
21/10/202423h00Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:XBIOXenetic Biosciences Inc
14/08/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XBIOXenetic Biosciences Inc
13/08/202422h32Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XBIOXenetic Biosciences Inc
12/02/202415h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XBIOXenetic Biosciences Inc
18/12/202323h18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XBIOXenetic Biosciences Inc
18/12/202323h16Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:XBIOXenetic Biosciences Inc
08/12/202323h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XBIOXenetic Biosciences Inc
08/12/202323h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XBIOXenetic Biosciences Inc
08/12/202323h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XBIOXenetic Biosciences Inc
08/12/202323h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XBIOXenetic Biosciences Inc
08/12/202323h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XBIOXenetic Biosciences Inc
13/11/202323h06Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:XBIOXenetic Biosciences Inc
13/11/202323h00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:XBIOXenetic Biosciences Inc
13/11/202314h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XBIOXenetic Biosciences Inc
09/11/202323h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XBIOXenetic Biosciences Inc
18/09/202318h21Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:XBIOXenetic Biosciences Inc
11/08/202314h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XBIOXenetic Biosciences Inc
10/08/202322h30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XBIOXenetic Biosciences Inc
15/06/202323h21Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:XBIOXenetic Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:XBIO

Kürzlich von Ihnen besucht

TG
D7G
Nel ASA
FX
EURUSD
Euro vs US Dollar
TG
BAYN
Bayer
TG
TUI1
Tui
TG
LHA
Deutsche Lufthansa
NYSE
MRK
Merck
DBI
MDAX
MDAX
TG
RHM
Rheinmetall
TG
CBK
Commerzbank
COIN
DOGEUSD
Dogecoin
DBI
TDXP
Tec DAX
TG
MBG
MercedesBenz
COIN
SOLUSD
Solana
NYSE
XOM
Exxon Mobil
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten